LEADER 02153nas  2200445-  450 
001 9910482015603321
005 20231116213017.0
011   $a2719-4523
035   $a(OCoLC)1262670582
035   $a(CKB)5590000000487038
035   $a(CONSER)--2022229150
035   $a(NjHacI)995590000000487038
035   $a(EXLCZ)995590000000487038
100   $a20210711a20209999  o--         -
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aRheumatology and immunology research
210  1$a[Berlin, Germany] :$cDe Gruyter Open Access,$d[2020]-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
327   $aBiomarkers for Treatment Response in Rheumatoid Arthritis: Where are they? -- 2020 Chinese Guidelines for the Diagnosis and Treatment of Systemic Lupus Erythematosus -- The Dawn of a New Era of Therapies in Systemic Lupus Erythematosus -- Characteristics and Long-term Outcomes of Patients with Lupus-related Protein-losing Enteropathy: A Retrospective Study -- Vision Loss, Multiple Cerebral Infarction, Ischemia of Extremities: Systemic Vasculitis or Cardiac Myxoma? -- Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis -- Risk of Malignancy and Biologic Therapy in Rheumatic Inflammatory Diseases: A Single-center Experience -- Air in the Eyelids! Pneumomediastinum and Periorbital Emphysema in a Patient of Dermatomyositis -- The History of Development of Rheumatology in China: From a Single Center to the Whole Country.
531 10$aRheumatol Immunol Res
531 0 $aRheumatol. Immunol. Res.
606   $aRheumatism
606   $aImmunology$xResearch$vPeriodicals
608   $aPeriodical.
608   $aPeriodicals.$2fast
615  0$aRheumatism.
615  0$aImmunology$xResearch
676   $a616.723
712 02$aNational Clinical Research Center for Dermatological and Rheumatologic Diseases of China,
801  0$bNjHacI
801  1$bNjHacl
906   $aJOURNAL
912   $a9910482015603321
996   $aRheumatology and Immunology Research$92218406
997   $aUNINA